# ALDER BIOPHARMACEUTICALS INC

ALDER BIOPHARMACEUTICALS INC is a company headquartered in Bothell, WA, United States.

## Company overview

- **Legal name:** ALDER BIOPHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Bothell, WA, United States
- **Fiscal year end:** December 31
- **SEC CIK:** 0001423824

## About

ALDER BIOPHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001423824, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-02-25, it reported annual revenue of USD 0; net income of USD -296,429,000; total assets of USD 426,239,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$296.4M (USD -296,429,000)
- **Total assets:** $426.2M (USD 426,239,000)
- **Cash and equivalents:** $87.9M (USD 87,865,000)
- **Operating cash flow:** -$250.8M (USD -250,850,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$288.9M (USD -288,879,000)
- **Total assets:** $303.1M (USD 303,136,000)
- **Cash and equivalents:** $76.9M (USD 76,896,000)

### FY2016 (period ended 2016-12-31)

- **Net income:** -$156.3M (USD -156,254,000)
- **Total assets:** $409.2M (USD 409,154,000)
- **Cash and equivalents:** $116.2M (USD 116,216,000)

### FY2015 (period ended 2015-12-31)

- **Net income:** -$85.5M (USD -85,470,000)
- **Total assets:** $400.0M (USD 400,027,000)
- **Cash and equivalents:** $206.5M (USD 206,492,000)

## Recent SEC filings

- Form SC 13G — filed 2019-10-31 — ALDER BIOPHARMACEUTICALS, INC.
- Form 8-K — filed 2019-10-22 — period 2019-10-18 — 8-K
- Form SC 13D — filed 2019-09-26 — SC 13D
- Form 8-K — filed 2019-09-16 — period 2019-09-15 — 8-K
- Form 8-K — filed 2019-08-06 — period 2019-08-06 — 8-K
- Form 10-Q — filed 2019-08-06 — period 2019-06-30 — 10-Q
- Form 8-K — filed 2019-05-24 — period 2019-05-23 — 8-K
- Form 8-K — filed 2019-05-02 — period 2019-05-02 — 8-K
- Form 8-K — filed 2019-05-02 — period 2019-05-02 — 8-K
- Form 10-Q — filed 2019-05-02 — period 2019-03-31 — 10-Q
- Form DEF 14A — filed 2019-04-30 — period 2019-05-23 — DEF 14A
- Form 8-K — filed 2019-04-12 — period 2019-04-09 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/alder-biopharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology